East Ocyon Bio: Financial Breakdown
Decoding financial health metrics of East Ocyon Bio
Total Revenue₹2.0 Lakh-60%Prev. FY
Total Expenses₹1.8 Cr117%Prev. FY
Profit After Tax₹-1.8 Cr-127%Prev. FY
Total Assets₹1.3 Cr-9%Prev. FY
Net Profit Margin-77.7%-364%Prev. FY
FAQs on Financials of East Ocyon Bio
No. In FY25, East Ocyon Bio reported a net loss of ₹3.5 Cr, so it was not profitable.
East Ocyon Bio's revenue grew 1514.5% year-on-year, from ₹2.0 Lakh in FY24 to ₹32.3 Lakh in FY25.
East Ocyon Bio's estimated EBITDA for FY25 was ₹-3.1 Cr, derived from its profit before tax, finance costs, and depreciation & amortisation.
In FY25, East Ocyon Bio posted revenue of ₹32.3 Lakh (up 1514.5% YoY) and a net loss of ₹3.5 Cr. Explore the full financials of East Ocyon Bio here...
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links